About 15.5 million Americans have used injectable diabetes medicines to lose weight. These drugs can cause risks that you ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

Health Canada has approved the weight-loss drug Wegovy to reduce the risk of non-fatal heart attacks, drug maker Novo Nordisk ...

Most patients still need to be managed by oral medications to treat diabetes and not injections, at least in the early stages ...

Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.

Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.

Amgen's experimental weight loss injection, MariTide, showed up to 20% weight loss in patients without diabetes and 17% in ...

Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The Health Products Regulatory Authority stressed there can be no guarantees as to what substances these online products ...

But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...